Clinical trial
The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
NCT00332397 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00332397 |
|---|---|
| Title | The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis |
| Official title | Randomized Comparison of 3 Limus Agent-Eluting Stents for the Reduction of Coronary Restenosis |
| Acronym | ISAR-TEST-2 |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | Rapamycin-eluting Stent, Zotarolimus-eluting Stent |
| Enrollment | 1,007 |
| Start date | Mar 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Jun 1, 2006 |
| Last update posted | Jun 17, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: